Some of the greatest opportunities and challenges in the biotechnology and pharmaceutical industries are dependent on innovations in materials development using both synthetic and biological sources: sensors and diagnostics, drug and gene delivery, novel devices, scaffolds, and biomimetics, materials for biotech processing.
Join industry partners and applied research leadership accelerating the development and deployment of new material solutions into products and society.
Featured Speakers:
Lisa Friedersdorf
National Nanotechnology Coordination Office
Mauro Ferrari
Houston Methodist Research Institute
Philip Demokritou
Harvard School of Public Health
Thomas Anchordoquy
University of Colorado School of Pharmacy
Thomas E. Twardowski
Integra Life Sciences Corporation
Shanta Dhar
University of Miami
Jeff Tza-Huei Wang
Johns Hopkins University
Radislav A. Potyrailo
GE Global Research, US
Kenneth J. Loh
University of California, San Diego
Martin E. Poitzsch
Aramco Research Center
William (Cy) Wilson
NASA Langley Research Center
Dorothy F. Farrell
National Cancer Institute
Puja Sapra
Pfizer
Laurent Levy
Nanobiotix SA, France
Anil Patri
U.S. Food and Drug Administration
Mansoor M. Amiji
Northeastern University
Scott Twary
Los Alamos National Laborator
Srinivas Iyer
Los Alamos National Laboratory
Aram Chung
Rensselaer Polytechnic Institute (RPI)
Jeff Tza-Huei Wang
Johns Hopkins University
Jean Berthier
CEA-LETI-Minatec, France
Edward Furlani
University at Buffalo (SUNY)
Kwang W. Oh
University at Buffalo (SUNY)
Richard B. Fair
Duke University
Steven Zullo
NIH/NIBIB
Greg Haugstad
University of Minnesota
Ryan Wagner
National Institute of Standards and Technology
Pierre Panine
Xenocs SA, France
Dalia Yablon
SurfaceChar LLC
Greg Haugstad
University of Minnesota
Ryan Wagner
National Institute of Standards and Technology
Pierre Panine
Xenocs SA, France
Key Speakers Include:
- Alex Aimetti, InVivo Therapeutics Corporation
- Anil Patri, U.S. Food and Drug Administration
- Aram Chung, Rensselaer Polytechnic Institute (RPI)
- C. Rebecca Locker, ExxonMobil Research and Engineering Co
- Corry Schuyler, Thermo Fisher Scientific
- Dalia Yablon, SurfaceChar LLC
- Daniel L. Alge, Texas A&M University
- David Rampulla, National Inst. for Biomedical Imaging & Bioengineering (NIBIB)
- Kristy Wood, Intellia Therapeutics, Inc.
- Dorothy F. Farrell, National Cancer Institute
- Elisabeth (Sabeth) Verpoorte, University of Groningen, The Netherlands
- Greg Haugstad, University of Minnesota
- Gregory Lanza, Washington University School of Medicine
- Hamid Ghandehari, University of Utah
- Ibrahim Tarik Ozbolat, Penn State
- Jean Berthier, CEA-LETI-Minatec, France
- Jeff Tza-Huei Wang, Johns Hopkins University
- Kenneth J. Loh, University of California, San Diego
- Laurent Levy, Nanobiotix SA, France
- Mansoor M. Amiji, Northeastern University
- Mauro Ferrari, Houston Methodist Research Inst.
- Michelle Bradbury, Cornell University
- Murat Guvendiren, New Jersey Institute of Technology (NJIT)
- Nathan Gianneschi, UCSD
- Phil Demokritou, Harvard School of Public Health
- Puja Sapra, Pfizer
- Radislav A. Potyrailo, GE Global Research, US
- Roger Proksch, Asylum Research
- Ryan Roeder, University of Notre Dame
- Samuel Achilefu, Washington University School of Medicine
- Schuyler Corry, Thermo Fisher Scientific
- Scott Twary, Los Alamos National Laboratory
- Shanta Dhar, University of Miami
- Sindy KY Tang, Stanford University
- Srinivas Iyer, Los Alamos National Laboratory
- Steven Zullo, NIH/NIBIB
- Thomas E. Twardowski, Integra Life Sciences Corporation
- Vicki Stone, Heriot-Watt University, Scotland
- Zhihong Nie, University of Maryland
